D-0008-2026 Class II Ongoing
FDA drug recall D-0008-2026 was initiated by Dr. Reddy's Laboratories, Inc. on September 26, 2025 and is designated Class II. Reason for recall: Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration. The recall status is ongoing. Affected quantity: 571 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- October 15, 2025
- Initiation Date
- September 26, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 571 vials
Product Description
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Reason for Recall
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Distribution Pattern
Nationwide within the USA.
Code Information
Lot # K250048